Predictive Factors for Macular Atrophy in Patients with Treated Myopic Macular Neovascularization
Macular atrophy after mMNV leads to irreversible visual loss. The baseline atrophic area predicts final macular atrophy. Initial SCT and the implemented treatment regimen (especially with a higher number of IVI) influence atrophy growth, although not significant in the multivariable model.
Authors
- Amândio Rocha‐Sousa (ORCID: https://orcid.org/0000-0001-8374-0298)
- Susana Costa Penas (ORCID: https://orcid.org/0000-0001-7696-1957)
- Manuel A. Falcão (ORCID: https://orcid.org/0000-0001-7852-809X)
- Alcina Ferreira
- Ângela Veloso Carneiro
- Inês Coelho-Costa (ORCID: https://orcid.org/0000-0002-5229-0236)
- João Nuno Beato
Institutions
- Universidade do Porto (PT)
- Hospital de São João (PT)
Publication Details
- Journal
- Clinical ophthalmology
- Published
- 2025-12-01
- DOI
- https://doi.org/10.2147/opth.s566595
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00